Medline Inc. IPO - What You Need to Know

Thinking about jumping into the Medline IPO? It is a massive name in the medical world. As of their November 2025 filing, the company is moving forward with plans to go public. Before you invest your hard-earned money, here is a simple guide to what you need to know.

1. What does this company actually do?

Think of Medline as the "Amazon of hospitals." If a medical facility needs surgical gloves, gowns, or bandages, Medline likely supplies it. They manufacture about one-third of their own products across 33 facilities. With 69 distribution centers and over 2,000 trucks, they deliver products directly to hospitals, often reaching 99% service levels. They operate in over 100 countries and employ 43,000 people.

2. How do they make money?

Medline generates revenue through two main channels:

• Medline Brand: They sell about 190,000 of their own products. Because they manufacture these items, they keep more of the profit compared to distributing other brands.
• Supply Chain Solutions: They distribute products for over 1,250 other brands, providing logistics and inventory management to healthcare providers.

Their "secret sauce" is the Prime Vendor model. They sign five-year contracts to be a hospital's main supplier. This creates a cycle: by lowering costs for the hospital, Medline builds deep trust. This trust helps them sell more Medline-branded goods, which drives higher profits.

3. Why is this business model strong?

Medline is incredibly "sticky." They have kept 98% of their Prime Vendor customers over the last five years. They do not just sell boxes; they sell clinical solutions. They employ clinicians and run "Medline University" programs to train hospital staff on product usage and patient outcomes. By becoming part of the hospital’s daily workflow, Medline becomes an essential partner rather than just another vendor.

4. What will they do with the money from this IPO?

The company plans to use the money primarily to pay down debt. This will lower their interest payments and strengthen their financial health. They will use the remaining funds for general business needs, including expanding and modernizing their distribution network—a priority, given they have already invested $1.6 billion in this area over the last five years.

5. What are the main risks?

• Pricing Pressure: Hospitals are under constant pressure to cut costs. This can lead to tough contract negotiations and lower profit margins for suppliers.
• Competition: Medline faces intense competition from large companies like McKesson and Cardinal Health, who may compete on price or service.
• Complex Ownership: The company uses a dual-class share structure. Insiders will hold "Class B" shares, which have more voting power than the "Class A" shares offered to the public. This means public shareholders will have little say in board decisions, executive pay, or major company deals.

6. Where will it trade and under what symbol?

Medline has applied to list on the Nasdaq under the ticker symbol "MDLN."

7. How much will it cost?

The company has not yet set a final price. A preliminary prospectus will be released closer to the offering date, which will list an initial price range. This range is a key indicator of how the company values itself and should be reviewed carefully.

How to prepare for the IPO

If you are interested in participating, here are three steps you can take:

1. Check the SEC Filing: Before the IPO date, search for "Medline" on the SEC EDGAR website. Look for the "S-1" filing; it contains the most detailed information about their financials and specific risks.
2. Watch for the Price Range: Pay attention to the news for the "roadshow" updates, where the company will announce their target price range.
3. Check your Brokerage: Not all brokerage platforms allow retail investors to buy shares at the initial IPO price. Check with your broker to see if they offer access to IPOs.

Disclaimer: I am an AI, not a financial advisor. IPOs can be very volatile, and you can lose money. Always read the official prospectus on the SEC’s EDGAR website before investing, and never invest money you cannot afford to lose.